148 related articles for article (PubMed ID: 36299674)
1. Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter's syndrome.
Vladimirovna TV; Romanovna OM; Nikolaevich BA; Miroslavovich KY; Anatolievich RO
Oxf Med Case Reports; 2022 Oct; 2022(10):omac111. PubMed ID: 36299674
[TBL] [Abstract][Full Text] [Related]
2. Richter's transformation in chronic lymphocytic leukemia.
Jain P; O'Brien S
Oncology (Williston Park); 2012 Dec; 26(12):1146-52. PubMed ID: 23413591
[TBL] [Abstract][Full Text] [Related]
3. Durable Response to Venetoclax Monotherapy in Richter's Syndrome: A Case Report and Review of Literature.
Kollipara R; Szymanski K; Mahon B; Venugopal P
J Hematol; 2019 Jun; 8(2):60-63. PubMed ID: 32300445
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Masses as an Unusual Manifestation of Relapse in a Case of Atypical Chronic Lymphocytic Leukemia with Prolymphocytoid Transformation and Complex Karyotype: A Diagnostic Dilemma and Treatment Challenge.
Aldapt MB; Soliman D; Szabados L; Sharaf Eldean MZ; Shwaylia HM; Abdulla MAJ; Yassin MA
Am J Case Rep; 2020 May; 21():e920411. PubMed ID: 32388531
[TBL] [Abstract][Full Text] [Related]
5. The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease.
Appleby N; Eyre TA; Cabes M; Jackson A; Boucher R; Yates F; Fox S; Rawstron A; Hillmen P; Schuh A
BMC Cancer; 2019 May; 19(1):471. PubMed ID: 31109313
[TBL] [Abstract][Full Text] [Related]
6. Tumor Lysis Syndrome Caused by Unrecognized Richter's Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression.
Chango Azanza JJ; Calle Sarmiento PM; Mathew Thomas V; Lopetegui Lia N; Kidwai N
Cureus; 2020 May; 12(5):e8145. PubMed ID: 32550064
[TBL] [Abstract][Full Text] [Related]
7. Sustained complete remission in Richter's syndrome.
Heslop HE; Fitzgerald PH; Beard ME
Cancer; 1987 Mar; 59(5):1036-9. PubMed ID: 3815263
[TBL] [Abstract][Full Text] [Related]
8. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome.
Robak T; Urbańska-Ryś H; Strzelecka B; Krykowski E; Bartkowiak J; Bĺoński JZ; Kordek R; Warzocha K
Eur J Haematol; 2001; 67(5-6):322-7. PubMed ID: 11872081
[TBL] [Abstract][Full Text] [Related]
9. Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy.
Mato AR; Wierda WG; Davids MS; Cheson BD; Coutre SE; Choi M; Furman RR; Heffner L; Barr PM; Eradat H; Ford SM; Zhou L; Verdugo M; Humerickhouse RA; Potluri J; Byrd JC
Haematologica; 2019 Nov; 104(11):2258-2264. PubMed ID: 30923097
[TBL] [Abstract][Full Text] [Related]
10. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.
Dabaja BS; O'Brien SM; Kantarjian HM; Cortes JE; Thomas DA; Albitar M; Schlette ES; Faderl S; Sarris A; Keating MJ; Giles FJ
Leuk Lymphoma; 2001 Jul; 42(3):329-37. PubMed ID: 11699397
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
12. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
13. Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease "sanctuary" during venetoclax treatment?
Dimou M; Bitsani A; Roumelioti M; Dimitrakopoulou A; Iliakis T; Pardalis V; Grafakos I; Kalyva S; Markopoulos A; Kyrtsonis MC; Panayiotidis P
Clin Case Rep; 2021 Apr; 9(4):2249-2253. PubMed ID: 33936674
[TBL] [Abstract][Full Text] [Related]
14. B-chronic lymphocytic leukemia showed triple transformation, to diffuse large B cell, CD20-negative, and T-cell neoplasm during ofatumumab treatment: a case report.
Imataki O; Uemura M
BMC Clin Pathol; 2018; 18():5. PubMed ID: 29796007
[TBL] [Abstract][Full Text] [Related]
15. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
16. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
[TBL] [Abstract][Full Text] [Related]
17. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
[TBL] [Abstract][Full Text] [Related]
18. Richter's syndrome: biology and therapy.
Yee KW; O'Brien SM; Giles FJ
Cancer J; 2005; 11(3):161-74. PubMed ID: 16053658
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL.
Tzankov A; Fong D
Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567
[TBL] [Abstract][Full Text] [Related]
20. Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
Bouclet F; Calleja A; Dilhuydy MS; Véronèse L; Pereira B; Amorim S; Cymbalista F; Herbaux C; de Guibert S; Roos-Weil D; Hivert B; Aurran T; Dupuis J; Blouet A; Tchernonog E; Laribi K; Dmytruck N; Morel P; Michallet AS; Dartigeas C; Tournilhac O; Nguyen-Khac F; Delmer A; Feugier P; Ysebaert L; Guièze R
Ann Hematol; 2021 Apr; 100(4):987-993. PubMed ID: 33495922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
